In its most recent SEC filing, Chemistry Wealth Management LLC disclosed a 59.2% increase in its UnitedHealth Group holdings during the third quarter. The fund added 6,022 shares to bring its total UNH position to 16,199 shares, making UnitedHealth Group the firm’s 18th largest holding at approximately 1.1% of its overall portfolio. At quarter end, the position was valued at $5.593 million, reflecting the firm’s confidence in the healthcare conglomerate’s long-term growth trajectory and stable cash-flow generation.

Several leading institutional investors made significant moves in the second quarter. Norges Bank initiated a new UNH stake valued at $3.84 billion, while Berkshire Hathaway entered with a $1.57 billion position. Dodge & Cox more than doubled its exposure, increasing its stake by 117.7% to 8.75 million shares, now worth $2.73 billion. Lone Pine Capital invested approximately $528 million in a new position, and Amundi boosted its holdings by 33.8%, adding 1.57 million shares to reach 6.19 million shares valued at $1.90 billion. Institutional ownership of UNH now stands at 87.86%, underscoring broad confidence among professional investors.

UNH has attracted bullish commentary from major research houses. Morgan Stanley raised its target price by 21% and assigned an overweight rating, while Royal Bank of Canada increased its target by 42% to reflect robust earnings momentum. Goldman Sachs initiated coverage with a buy recommendation, and UBS boosted its target by 14%, reflecting positive outlook on Optum’s margin expansion. Zacks Research moved the stock from strong sell to hold, citing valuation support. In total, 17 analysts rate the stock as a Buy, nine as Hold and three as Sell, yielding a consensus rating of Hold and an average target of $385.54.

UnitedHealth Group reported third-quarter non-GAAP EPS of $2.92, surpassing the consensus estimate by $0.05, on revenue of $113.16 billion, in line with analyst forecasts. Revenue grew 12.2% year-over-year, driven by double-digit growth in both UnitedHealthcare premiums and Optum services. The company achieved a net margin of 4.04% and a return on equity of 19.23%. During the quarter, UnitedHealth declared a dividend of $2.21 per share, representing an annualized payout of $8.84 and a yield of 2.7%, with a payout ratio of 46.14%. Equities analysts now forecast full-year EPS of 29.54, reflecting confidence in sustained earnings growth into the next fiscal year.